* Al-Biruni Journal for Humanities and Social Sciences is committed to upholding the highest standards of publishing ethics and takes all possible measures against any publishing malpractice.
* The Editorial Board is responsible, among other things, for preventing publishing malpractice.
* Unethical behavior is unacceptable, and Al-Biruni Journal for Humanities and Social Sciences does not tolerate any form of plagiarism.
* Authors submitting articles confirm that the contents of the manuscripts are original. Furthermore, the authors' letter also indicates that the manuscript has not been previously published in any language, either in whole or in part, and is not currently being submitted for publication elsewhere. Editors, authors, and reviewers of Al-Biruni Journal for Humanities and Social Sciences must fully adhere to good publishing practice and accept responsibility for fulfilling the following duties and responsibilities as set forth in the Code of Conduct for Journal Editors.
* All submitted manuscripts undergo a rigorous peer review process by experts in the field of the particular manuscript.
* The review process is double-blind peer review.
*Factors considered in the review are scientific significance, linguistic and grammatical soundness, thoroughness of investigation, and scientific originality.
*Possible decisions include: 1. Accept, 2. Accept with revisions, or 3. Reject.
*If authors are encouraged to revise and resubmit their submission, there is no guarantee that the revised submission will be accepted.
*Rejected manuscripts will not be re-reviewed.

Publication Ethics
* All published articles must comply with accepted standards of research and publication ethics.
* Corrections, retractions, or expressions of concern will be issued as necessary to maintain the integrity of the scholarly record.
* The journal adheres to international guidelines such as those provided by COPE (Committee on Publication Ethics), ICMJE (International Committee of Medical Journal Editors), and WAME (World Association of Medical Editors).

 Transparency and Accountability
The journal is committed to full transparency regarding its ethical policies. All authors and readers are encouraged to report any suspected ethical violations. The editorial board will take appropriate actions in line with international best practices.
 
*The permissible plagiarism rate is only 15%, and the use of artificial intelligence techniques is absolutely prohibited (0%)

Originality 
All submitted manuscripts must be original. Manuscripts which have already been published by another journal or are being considered for publication will not be accepted. By submitting a manuscript, the author(s) acknowledge that the paper in question is not under consideration by another journal, and will not be submitted to such a journal until and unless a final written rejection decision from Al-Biruni Journal for Humanities and Social Sciences.

Authorship
The authorship listing should include the ‘lead’ author as well as all individuals who have contributed directly to the production of the work at intellectual and conceptual levels. Other individuals who have made additional contributions to the paper can be listed in the Acknowledgment section. Acknowledgment of funding sources and possible conflict of interest must also be made explicit.

Conflict of interest
Any potential or real conflict of interest must be declared to the editors. Papers received by editors of the journal or Board Members will be handled transparently and in the most appropriate way to avoid any possible bias in the review process. Editors will avoid making decisions on manuscripts that conflict with their own interest, or those addressing an issue in which they stand to gain financially. If they may have a perceived or possible conflict of interest, they should delegate handling of any decision to other editors.

Policy on Human and Animal Rights 
The journal requires that all research involving human participants complies with the Declaration of Helsinki Helsinki and relevant national or institutional ethical guidelines. Authors must provide evidence of ethical approval from an appropriate review board and obtain informed consent from participants.
For research involving animals, the journal mandates adherence to recognized standards for animal care and use, including minimizing pain and suffering, and obtaining approval from relevant institutional animal care committees.
Manuscripts that do not comply with these ethical standards will not be considered for publication. Authors are also expected to declare any potential conflicts of interest related to ethical issues.

Peer review process
Manuscripts are first reviewed by the editorial office to check if they are in line with the scope of the journal and if they meet all its specific requirements. Once a manuscript successfully completes the editorial office review process it is sent for blind peer reviewing to two anonymous reviewers who have expertise and special knowledge of the subject area of the manuscript. The peer review system is double-blind so that both authors’ and reviewers’ identities are concealed. editors will approach peer reviewers “who have not previously co-published extensively with the author(s), who are for this and other reasons free of known bias in relation to the subject matter, the author(s) and/or their institutions, and who can cover, from a position of authority and peer expertise, the topic(s) dealt with in the paper concerned.” Reviewers are invited to review the manuscript by sending them the abstract of the manuscript. Upon acceptance to review the manuscript, the full text of the manuscript is sent to the reviewers after the author(s) have been concealed. Reviewers are required to provide a report in writing with clear recommendations for acceptance of the paper, with or without any revision, or rejection. If the two reports differ widely, the editor may invite a third reviewer. The reviewing process relies on the availability of qualified and expert reviewers and it may take up to 2 to 8 weeks to complete. The Al-Biruni Journal for Humanities and Social Sciences endeavors to have papers reviewed within a one to four week period where possible. The review process may, however, take longer than this. Al-Biruni Journal for Humanities and Social Sciences editors mediates the blind reviews with authors. All reviewers’ comments are sent to the author(s) who are requested to make the necessary adjustments and resubmit their manuscripts to the editors. The journal’s editors will check that all recommended changes have been substantively attended to. Authors are required to submit a report to the editors, documenting how they have responded to reviewers’ suggestions and recommendations, using the online submission.

Accessibility
Al-Biruni Journal for Humanities and Social Sciences  is an open access journal, available at no charge and the PDF versions of all papers are available on the journal’s website https://al-biruni-journal.jo 


Author Responsibilities
  • Authors must certify that their manuscript is their original work.
  • Authors must certify that the manuscript has not been previously published elsewhere.
  • Authors must certify that the manuscript is not currently being considered for publication elsewhere.
  • Authors are obligated to provide error corrections and make any requested amendments.
  • All authors named in the manuscript must have made a significant contribution to the research.
  • Authors must state that all data in the manuscript are factual.
  • Authors must notify the editors of any conflicts of interest.
  • Authors must identify all sources used in creating their manuscript.
  • Authors must report any errors they discover in their published manuscript to the editors.

Reviewer Responsibilities:
  • Reviewers should maintain the confidentiality of all information related to the papers and treat them as privileged information.
  • Reviews should be conducted objectively without directing any personal criticism at the author.
  • Reviewers should clearly express their opinions with supporting arguments.
  • Reviewers should identify relevant published works not cited by the authors.
  • Reviewers should also bring to the attention of the editor-in-chief any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
  • Reviewers should not review manuscripts in which they have a conflict of interest resulting from competitive, collaborative, or other relationships or ties with any of the authors, companies, or institutions associated with the papers.

Editor Responsibilities:
  • Editors have full responsibility and authority to reject/accept an article.
  • Editors are responsible for the overall content and quality of a publication.
  • Editors must always consider the needs of authors and readers when attempting to improve a publication.
  • Editors must ensure the quality of papers and the integrity of the academic record.
  • Editors must publish errata pages or make corrections when necessary.
  • Editors must have a clear picture of the sources of research funding.
  • Editors must base their decisions solely on the importance, originality, clarity, and relevance of the paper to the scope of the publication.
  • Editors must not reverse their own decisions or overrule those of previous editors without serious reason.
  • Editors must maintain the anonymity of reviewers.
  • Editors must ensure that all published research material complies with internationally accepted ethical guidelines.
  • Editors must accept a paper only when they are reasonably certain.
  • Editors must act if they suspect misconduct, whether the paper is published or not, and make all reasonable attempts to pursue a resolution of the problem.
  • Editors should accept papers based on suspicion; they must have evidence of misconduct.
  • Editors should not allow any conflict of interest between staff, authors, reviewers, and board members

Compliance with ICMJE Recommendations
  • This journal follows the recommendations of the International Committee of Medical Journal Editors (ICMJE) for the conduct, reporting, editing, and publication of scholarly work in medical journals, as outlined at ICMJE .
  • Authors are required to prepare their manuscripts in accordance with the ICMJE Recommendations and to complete the ICMJE Conflict of Interest Disclosure Form, which can be downloaded from:Disclosure of Interest  .
  • The journal also adheres to the ICMJE guidelines on authorship criteria, ethical considerations in the conduct and reporting of research, clinical trial registration, and data sharing statements for clinical trials.
  • All submissions are expected to comply with the highest standards of integrity and transparency as promoted by the ICMJE.

Advertising Policy
The journal accepts advertising that is relevant to its readers and consistent with its mission to advance scientific knowledge. All advertisements are subject to editorial approval, and acceptance of advertising does not imply endorsement by the journal or its editorial board.

* Independence: Advertising content is clearly distinguished from editorial content and has no influence on editorial decisions.

* Ethical Standards: Advertisements must comply with applicable laws, regulations, and ethical standards, particularly in relation to medical and healthcare products.

* Rejection Rights: The journal reserves the right to decline or remove any advertisement that is misleading, inappropriate, or conflicts with the journal’s values.

* Transparency: Sponsorships and commercial support are disclosed to maintain transparency and reader trust.


Handling Corrections, Retractions, and Expressions of Concern
The journal maintains strict procedures to uphold the accuracy and integrity of the scientific record.
  1. Corrections: Minor errors that do not affect the study’s conclusions are addressed through a published correction notice linked to the original article.
  2. Retractions: Articles found to contain serious errors, misconduct, or ethical violations are retracted following a thorough investigation, with the retraction notice clearly stating the reasons.
  3. Expressions of Concern: When potential issues are identified but investigations are ongoing, the journal may issue an editorial expression of concern to alert readers while maintaining transparency.
All actions are guided by international standards (e.g., COPE guidelines) and are clearly communicated to authors, readers, and indexing services to preserve trust in the journal.
The journal fully adheres to the COPE guidelines on ethics and scientific integrity, and authors are required to adhere to sound research practices, including avoiding plagiarism and duplicate publication, disclosing any conflicts of interest, and obtaining necessary ethical approvals when required.



** CONSENT TO USE OF COOKIES.
By using this Site, you agree that we may collect your personal information which may be obtained by Cookiebot  and that our use of such personal information will be in accordance with European Data Protection Board (EDPB) 

 LINKS.
Links on this Site may provide access to other Internet sites that are not maintained or controlled by "Noor Al Ilm for Publishing and Distribution" . Such external Internet sites contain information created, published, maintained or otherwise posted by organizations and entities independent of "Noor Al Ilm for Publishing and Distribution". "Noor Al Ilm for Publishing and Distribution" is not responsible for the content of those sites. Links on this Site may also provide access to other entities affiliated with "Noor Al Ilm for Publishing and Distribution" . This Agreement applies only to the Services offered at the Site. Your use of any website other than the Site will be subject to the terms and conditions posted on that website. "Noor Al Ilm for Publishing and Distribution" takes no responsibility and assumes no liability for any content posted by any third party or on any other website, nor does Sage approve, endorse, verify or certify information available at any external site or linked addresses. "Noor Al Ilm for Publishing and Distribution" takes no responsibility and assumes no liability for the privacy practices of such third parties.

PROHIBITED ACTIVITIES
You are responsible for all of your activities and those authorized users you permit to access the Site and/or the Services through your facilities in accordance with your Access Agreement or other agreement, if applicable. You may not violate or attempt to violate the security of the Site and/or the Services. Accordingly, you shall not (a) circumvent or attempt to circumvent any security measures designed to control access to the Site and/or the Services or in any way obtain or attempt to obtain unauthorized access to or use of any elements or portion of the Site and/or the Services; (b) access data or materials not intended for you; (c) log into a server or account which you are not authorized to access; (d) attempt to probe, scan or test the vulnerability of a system or network or to breach security or authentication measures without proper authorization; (e) use this Site and/or the Services to infringe the intellectual property rights of others in any way – be advised that it is our policy to terminate the accounts of repeat infringers of copyright; (f) use this Site and/or the Services or make any attempt to penetrate, modify or manipulate this Site and/or the Services or any of “Noor Al Ilm for Publishing and Distribution’s” hardware or software in order to: invade the privacy of, obtain the identity of, or obtain any personal information about any third party; (g) attempt to interfere with service to any user, host or network, including without limitation, by submitting any harmful code, trojan horse, worm or virus to the Site and/or the Services, any denial of service attack, overloading, mailbombing or attempted crashing of the Site and/or the Services or the software or hardware used in providing the Site and/or the Services; (h) spoof or otherwise impersonate any individual or entity, or forge, delete or alter any part of TCP/IP packet header information in any e-mail or other posting; (i) create "deep links" into pages other than the front page of the Site; or (j) assist or permit any persons in engaging in any of the activities described above.

CONSEQUENCES OF UNACCEPTABLE USE.
We reserve all rights, including without limitation the right to investigate and to involve and cooperate with law enforcement authorities, and to pursue a civil lawsuit and/or criminal prosecution for any alleged or actual illegal activities involving this Site and/or any of the Services, as well as the right to terminate your access to the Site and/or the Services.

EPRESENTATIONS; WARRANTY DISCLAIMER.

Subject to the terms below, “Noor Al Ilm for Publishing and Distribution” represents that it has the right to license the rights granted under this Agreement.
“Noor Al Ilm for Publishing and Distribution” MAKES NO REPRESENTATION OR WARRANTY, AND EXPRESSLY DISCLAIMS ANY RESPONSIBILITY FOR LIABILITY WITH RESPECT TO YOUR USE OF THE SITE AND/OR THE SERVICES OR THE RESULTS OBTAINED FROM YOUR USE OF THE SITE OR THE SERVICES, INCLUDING, BUT NOT LIMITED TO, LIABILITY ASSOCIATED WITH ERRORS OR OMISSIONS, LIBEL, INFRINGEMENT OR VIOLATION OF RIGHTS OF PUBLICITY, PRIVACY, INTELLECTUAL PROPERTY RIGHTS, OR MORAL RIGHTS, OR THE DISCLOSURE OF CONFIDENTIAL INFORMATION.
MOREOVER, EXCEPT FOR THE EXPRESS WARRANTIES STATED HEREIN, THE SITE AND THE SERVICES ARE PROVIDED ON AN "AS IS" AND “AS AVAILABLE” BASIS, AND “Noor Al Ilm for Publishing and Distribution” DISCLAIMS ANY AND ALL OTHER WARRANTIES, CONDITIONS, COVENANTS, OR REPRESENTATIONS (EXPRESS, IMPLIED, ORAL OR WRITTEN), RELATING TO THE SITE AND/OR THE SERVICES OR TO ANY PARTS THEREOF, INCLUDING, WITHOUT LIMITATION, ANY AND ALL IMPLIED WARRANTIES OF QUALITY, PERFORMANCE, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. “Noor Al Ilm for Publishing and Distribution” ALSO MAKES NO WARRANTIES RESPECTING AND SHALL HAVE NO RESPONSIBILITY FOR ANY HARM THAT MAY BE CAUSED BY THE TRANSMISSION OF A COMPUTER VIRUS, WORM, TIME BOMB, LOGIC BOMB OR OTHER SUCH COMPUTER PROGRAM OR OTHERWISE. “Noor Al Ilm for Publishing and Distribution” FURTHER EXPRESSLY DISCLAIMS ANY WARRANTY OR REPRESENTATION TO ANY THIRD PARTY.
NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY, “Noor Al Ilm for Publishing and Distribution” SHALL NOT BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES, INCLUDING BUT NOT LIMITED TO LOSS OF DATA, BUSINESS INTERRUPTION, OR LOSS OF PROFITS, ARISING OUT OF THE USE OF OR THE INABILITY TO USE THE SITE AND/OR THE SERVICES (EVEN IF “Noor Al Ilm for Publishing and Distribution” HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES). IN ADDITION, “Noor Al Ilm for Publishing and Distribution|” SHALL NOT BE LIABLE FOR ANY DAMAGES OR LIABILITY THAT RESULT OR ARISE FROM THE RESULTS OF YOUR USE OR YOUR INABILITY TO USE THE SITE AND/OR ANY OTHER PART OF THE SERVICES. BECAUSE SOME STATES OR JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU. BUT, TO THE EXTENT THE FOREGOING LIMITATIONS OF LIABILITY ARE, IN WHOLE OR IN PART, HELD TO BE INAPPLICABLE OR UNENFORCEABLE FOR ANY REASON, THEN THE AGGREGATE LIABILITY OF “Noor Al Ilm for Publishing and Distribution” FOR ANY REASON AND UPON ANY CAUSE OF ACTION (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE, STRICT LIABILITY AND OTHER ACTIONS IN CONTRACT OR TORT) ARISING OUT OF OR IN ANY WAY RELATED TO THE SITE, THE SERVICES AND/OR THIS AGREEMENT SHALL BE LIMITED TO YOUR DIRECT DAMAGES ACTUALLY INCURRED UP TO TWO HUNDRED FIFTY DOLLARS ($250).

8. INDEMNITY.
You agree to indemnify and hold “Noor Al Ilm for Publishing and Distribution” harmless, and, at “Noor Al Ilm for Publishing and Distribution’s|” request, to defend “Noor Al Ilm for Publishing and Distribution” from and against any claim, demand, cause of action, debt, damage, loss or liability, including reasonable attorneys’ fees, to the extent that such action is based upon, arises out of, or relates to: (i) your use of (or inability to use) this Site and/or the Services; (ii) your violation of the terms and conditions of this Agreement; (iii) the infringement by you, or any other person using your ID, Password and/or account, of any right of any person or entity; or (iv) any other activities of yours accomplished using this Site and/or the Services. You agree to cooperate as fully as reasonably required in the defense of any such claim. |”Noor Al Ilm for Publishing and Distribution|” reserves the right, at its own expense, to assume the exclusive defense and control of any matter subject to indemnification by you. This indemnity shall be in addition to and not limited by any other indemnity.

1. Ethical Approval
All research involving human participants must have been approved by an appropriate Institutional Review Board (IRB) or Ethics Committee prior to commencement of the study.
Authors must state in the manuscript:
  • The name of the approving institution
  • Approval number (if applicable)
  • Date of approval
Research must comply with the principles of the Declaration of Helsinki and relevant national regulations.
 
2. Informed Consent
Authors must confirm that:
  • Written informed consent was obtained from all participants.
  • For minors or legally incapable individuals, consent was obtained from legal guardians.
  • Participants were informed of the purpose of the study, risks, and their right to withdraw at any time without penalty.
A statement confirming this must appear in the manuscript under a dedicated section titled:
“Ethics Approval and Consent to Participate.”
 
3. Confidentiality and Anonymity
Authors must ensure:
  • No identifying personal data (names, ID numbers, photos without consent) are published.
  • Data are anonymized where possible.
  • Any potentially identifying information is published only with explicit written permission.
 
4. Vulnerable Populations
Research involving vulnerable groups (children, prisoners, refugees, individuals with cognitive impairments, etc.) must demonstrate:
  • Additional safeguards
  • Justification for inclusion
  • Compliance with international ethical standards
 
5. Clinical Trials Registration
If applicable, clinical trials must be registered in a publicly accessible registry prior to participant enrollment (e.g., ClinicalTrials.gov or equivalent registry).
 
6. Data Protection Compliance
Research must comply with relevant data protection laws (e.g., GDPR for European research).
 
7. Consequences of Non-Compliance
Failure to provide ethical documentation may result in:
  • Rejection prior to peer review
  • Retraction post-publication
  • Notification to affiliated institutions

Consent and Confidentiality for Human Subjects
"Al-Biruni Journal of Humanities and Social Sciences "endorses the International Committee of Medical Journal Editors (ICMJE) recommendations for reporting of research and other material published in scholarly journals, including reporting and reviewing of human and animal research. Authors who choose to include information or clinical photographs that could allow readers to identify the patient must prove they have permission to include or reproduce the content. This includes appropriate permission from the author and publisher of the original work or written and signed consent to publish from each patient. Authors must make all reasonable efforts to protect patient anonymity, whether using original content or reproducing content from a primary source.

Allegations of Misconduct
Allegations of research or publication misconduct are examined in a fair, timely, and thorough investigation by qualified personnel, which may include Editorial Committee Members, the Editor-in-Chief and Associate Editor-in-Chief of "Al-Biruni Journal of Humanities and Social Sciences", and the "Al-Biruni Journal of Humanities and Social Sciences" Ethics Committee. Complaints against "Al-Biruni Journal of Humanities and Social Sciences" staff are assessed by the company’s Human Resources Department.


Hazards and human or animal subjects
If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.
If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects.  The privacy rights of human subjects must always be observed.
For human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans11.  All animal experiments should comply with the ARRIVE guidelines12 and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act 1986 and associated guidelines13, or  EU Directive 2010/63/EU on the protection of animals used for scientific purposes14, or the U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals and, as applicable, the Animal Welfare Act15.
Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an "Noor Al Ilm for Publishing and Distribution" publication. Written consents must be retained by the author and copies of the consents or evidence that such consents have been obtained must be provided to "Noor Al Ilm for Publishing and Distribution" on request16.

Reporting sex- and gender-based analyses
Reporting guidance
For research involving or pertaining to humans, animals or eukaryotic cells, investigators should integrate sex and gender-based analyses (SGBA) into their research design according to funder/sponsor requirements and best practices within a field. Authors should address the sex and/or gender dimensions of their research in their article. In cases where they cannot, they should discuss this as a limitation to their research's generalizability. Importantly, authors should explicitly state what definitions of sex and/or gender they are applying to enhance the precision, rigor and reproducibility of their research and to avoid ambiguity or conflation of terms and the constructs to which they refer (see Definitions section below). Authors can refer to the Sex and Gender Equity in Research (SAGER) guidelines and the SAGER guidelines checklist. These offer systematic approaches to the use and editorial review of sex and gender information in study design, data analysis, outcome reporting and research interpretation - however, please note there is no single, universally agreed-upon set of guidelines for defining sex and gender.

Definitions
Sex generally refers to a set of biological attributes that are associated with physical and physiological features (e.g., chromosomal genotype, hormonal levels, internal and external anatomy). A binary sex categorization (male/female) is usually designated at birth ("sex assigned at birth"), most often based solely on the visible external anatomy of a newborn. Gender generally refers to socially constructed roles, behaviors, and identities of women, men and gender-diverse people that occur in a historical and cultural context and may vary across societies and over time. Gender influences how people view themselves and each other, how they behave and interact and how power is distributed in society. Sex and gender are often incorrectly portrayed as binary (female/male or woman/man) and unchanging whereas these constructs actually exist along a spectrum and include additional sex categorizations and gender identities such as people who are intersex/have differences of sex development (DSD) or identify as non-binary. Moreover, the terms "sex" and "gender" can be ambiguous--thus it is important for authors to define the manner in which they are used. In addition to this definition guidance and the SAGER guidelines,.
Author contributions
For transparency, we require corresponding authors to provide co-author contributions to the manuscript using the relevant CRediT roles. The CRediT taxonomy includes 14 different roles describing each contributor's specific contribution to the scholarly output. The roles are: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; and Writing - review & editing. Note that not all roles may apply to every manuscript, and authors may have contributed through multiple roles.

Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.